This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
NA Accortt , JW Waterbor , C Beall , G Howard (2002). Chronic disease mortality in a cohort of smokeless tobacco users. American Journal of Epidemiology 156, 730–737.
K Asplund (2003). Smokeless tobacco and cardiovascular disease. Progress in Cardiovascular Diseases 45, 383–394.
K Asplund , S Nasic , U Janlert , B Stegmayr (2003). Smokeless tobacco as a possible risk factor for stroke in men: a nested case-control study. Stroke 34, 1754–1759.
JE Audrain , RC Klesges , LM Klesges (1995). Relationship between obesity and the metabolic effects of smoking in women. Health Psychology 14, 116–123.
G Bolinder , L Alfredsson , A Englund , U de Faire (1994). Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. American Journal of Public Health 84, 399–404.
N Breslau , EO Johnson , E Hiripi , R Kessler (2001). Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Archives of General Psychiatry 58, 810–816.
M Curvall , L Romert , E Norlen , CR Enzell (1987). Mutagen levels in urine from snuff users, cigarette smokers and non tobacco users – a comparison. Mutation Research 188, 105–110.
KO Fagerstrom , EB Schildt (2003). Should the European Union lift the ban on snus? Evidence from the Swedish experience. Addiction 98, 1191–1195.
KO Fagerstrom , NG Schneider (1989). Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine 12, 159–182.
E Fernandez , M Garcia , A Schiaffino , JM Borras , M Nebot , A Segura (2001). Smoking initiation and cessation by gender and educational level in Catalonia, Spain. Preventive Medicine 32, 218–223.
J Foulds , L Kozlowski (2007). Snus – what should the public-health response be? Lancet 369, 1976–1978.
J Foulds , MB Steinberg , JM Williams , DM Ziedonis (2006). Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug and Alcohol Review 25, 59–71.
AH Furberg , C Bulik , P Lichtenstein , N Pedersen , PF Sullivan (2006). Patterns and prevalence of tobacco use in the Swedish Twin Registry. Addiction 101, 1509–1515.
N Gray (2005). Mixed feelings on snus. Lancet 366, 966–967.
FE Harrell Jr., KL Lee , DB Mark (1996). Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine 15, 361–387.
T Hastie , R Tibshiranti , J Friedman (2001). The Elements of Statistical Learning: Data Mining, Inference and Prediction. Springer: New York.
MP Hergens , A Ahlbom , T Andersson , G Pershagen (2005). Swedish moist snuff and myocardial infarction among men. Epidemiology 16, 12–16.
F Huhtasaari , V Lundberg , M Eliasson , U Janlert , K Asplund (1999). Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. Journal of the American College of Cardiology 34, 1784–1790.
E Janzon , G Engstrom , M Lindstrom , G Berglund , B Hedblad , L Janzon (2005). Who are the ‘quitters’? A cross-sectional study of circumstances associated with women giving up smoking. Scandinavian Journal of Public Health 33, 175–182.
SE Johansson , K Sundquist , J Qvist , J Sundquist (2005). Smokeless tobacco and coronary heart disease: a 12-year follow-up study. European Journal of Cardiovascular Prevention and Rehabilitation 12, 387–392.
J Lagergren , R Bergstrom , A Lindgren , O Nyren (2000). The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. International Journal of Cancer 85, 340–346.
F Lewin , SE Norell , H Johansson , P Gustavsson , J Wennerberg , A Biorklund , LE Rutqvist (1998). Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 82, 1367–1375.
MD Li , JK Kane , O Konu (2003). Nicotine, body weight and potential implications in the treatment of obesity. Current Topics in Medical Chemistry 3, 899–919.
KY Liang , SL Zeger (1986). Longitudinal data analysis using general linear models. Biometrika 73, 13–22.
P Lichtenstein , U De Faire , B Floderus , M Svartengren , P Svedberg , NL Pedersen (2002). The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. Journal of Internal Medicine 252, 184–205.
E Lunell , M Lunell (2005). Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study. Nicotine and Tobacco Research 7, 397–403.
J Luo , W Ye , K Zendehdel , J Adami , HO Adami , P Boffetta , O Nyren (2007). Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 369, 2015–2020.
M Osler , E Prescott , N Godtfredsen , HO Hein , P Schnohr (1999). Gender and determinants of smoking cessation: a longitudinal study. Preventive Medicine 29, 57–62.
BG Osterdahl , C Jansson , A Paccou (2004). Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. Journal of Agricultural and Food Chemistry 52, 5085–5088.
EM Perrin , KB Flower , AS Ammerman (2005). Pediatricians' own weight: self-perception, misclassification, and ease of counseling. Obesity Research 13, 326–332.
PG Persson , S Carlsson , L Svanstrom , CG Ostenson , S Efendic , V Grill (2000). Cigarette smoking, oral moist snuff use and glucose intolerance. Journal of Internal Medicine 248, 103–110.
A Radzius , JJ Gallo , DH Epstein , DA Gorelick , JL Cadet , GE Uhl , ET Moolchan (2003). A factor analysis of the Fagerstrom Test for Nicotine Dependence (FTND). Nicotine Tobacco Research 5, 255–260.
L Ramstrom (2003 b). Snus: part of the problem or part of the solution? Addiction 98, 1198–1199; discussion 1204–1207.
LM Ramstrom , J Foulds (2006). Role of snus in initiation and cessation of tobacco smoking in Sweden. Tobacco Control 15, 210–214.
B Rodu , C Jansson (2004). Smokeless tobacco and oral cancer: a review of the risks and determinants. Critical Reviews in Oral Biology and Medicine 15, 252–263.
B Rodu , B Stegmayr , S Nasic , K Asplund (2002). Impact of smokeless tobacco use on smoking in northern Sweden. Journal of Internal Medicine 252, 398–404.
B Rodu , B Stegmayr , S Nasic , P Cole , K Asplund (2004). The influence of smoking and smokeless tobacco use on weight amongst men. Journal of Internal Medicine 255, 102–107.
KJ Rothman , S Greenland (1998). Modern Epidemiology. Lippincott-Raven: Philadelphia.
EB Schildt , M Eriksson , L Hardell , A Magnuson (1998). Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. International Journal of Cancer 77, 341–346.
RA Schnoll , C Lerman (2006). Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opinion in Emerging Drugs 11, 429–444.
B Stegmayr , M Eliasson , B Rodu (2005). The decline of smoking in northern Sweden. Scandinavian Journal of Public Health 33, 321–324; discussion 243.
W Ye , AM Ekstrom , LE Hansson , R Bergstrom , O Nyren (1999). Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. International Journal of Cancer 83, 223–229.